Startup profile for BRAMI: latest funding, latest known valuation, total disclosed funding, investors, status, sources, and why the company is interesting. Part of the Venture Capital Tracker startup directory.

Startup profile · funding coverage

BRAMI funding, valuation and investors

High-protein Mediterranean pasta from lupini beans — NYC consumer brand.

Keep track of BRAMI

Save this profile to your VCT watchlist for a quick return.

View watchlist

Funding, valuation & investors

Answer-first snapshot

Latest funding

Series B

$33M · May 2026

Latest known valuation

Not publicly disclosed

Total disclosed equity funding

$33M

Excludes debt, grants, acquisitions, secondaries, and IPO proceeds.

Current status

private

series b · New York, NY

Investors in latest funding

Other: Lerer Hippeau

Sources: latest funding Last verified: 2026-07-25

Overview

BRAMI makes Mediterranean-inspired high-protein pasta from lupini beans, sold in national retail. VMG Partners led a $33M Series B in May 2026 with La Molisana, Pentland Ventures, Lerer Hippeau, and Gather Ventures participating — roughly $43.8M total equity per AlleyWatch. The round funds manufacturing capacity, supply chain, and U.S. expansion.

Why BRAMI is interesting

CPG investors fund repeat purchase and margin after promo — BRAMI's Series B from VMG signals protein pasta survived Whole Foods/Walmart trials.

Product & use cases

Shelf-stable and fresh pasta products with elevated protein from lupini beans, positioned as better-for-you Italian-style staples.

  • High-protein household pasta meals
  • Retail expansion in grocery chains
  • DTC and omnichannel brand growth

Key facts

  • Series B (May 2026): $33M led by VMG Partners
  • ~$43.8M total equity per AlleyWatch
  • Lerer Hippeau participant
  • NYC HQ consumer brand

Funding history (newest first)

Investors in our directory

Funds linked from BRAMI's profile — open a fund page for stage focus and related deal articles.

Competitive landscape

Edge: VMG growth equity validation and Lerer Hippeau NYC consumer network.

Protein pasta is crowded on shelf; BRAMI must defend velocity and gross margin post-promo — VMG due diligence implies metrics passed retail trials.

  • Barilla / De Cecco incumbent

    Traditional pasta giants adding protein lines.

  • Chickpea/lentil pasta brands direct

    Better-for-you pasta aisle competitors.

  • Homemade protein meals alternative

    Non-pasta protein sources.

Notable stories

  • PR Newswire May 2026: VMG leads protein pasta scale-up — supply chain and national retail focus.
  • VCT: May 2026 reminder not every headline was AI — food growth equity still active.

Industries

Consumer

Related funding articles

Venture Capital Tracker pieces that cover BRAMI's financing or category context.

FAQs about BRAMI

Practical answers founders, operators, and investors typically search for.

High-protein Italian-style pasta from lupini beans.
$33M Series B May 2026; ~$43.8M total.
VMG Partners — not in VCT directory.
Lerer Hippeau participated. See /fund/lerer-hippeau.
New York City per VCT.
Both protein-forward pasta; different base ingredients and brand positioning.
National expansion focus post-Series B.
Private; VMG growth rounds imply retail velocity targets.
Legume base for BRAMI's protein pasta formulation.
Consumer macro trend toward higher-protein convenient meals.

By Venture Capital Tracker

Last updated:

Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.